Health Sciences Portfolio

Health Sciences Portfolio reported 139 holdings worth US$381M as of Jun 30, 2026 (Form N-PORT)

As of Jun 30, 2026 · Filed Aug 11, 2026

Health Sciences Portfolio reported 139 holdings worth US$381M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. Filed Aug 11, 2026 (Form N-PORT).

Holdings
139
Value as reported
US$381M

The filing in full

CompanySharesValue as reported% of portfolio
Eli Lilly And Company39,510US$47.4M12.4%
Johnson & Johnson117KUS$29.6M7.8%
Unitedhealth Group Incorporated56,143US$23.3M6.1%
Merck & Company, Inc.156KUS$20M5.2%
Abbvie Inc.76,485US$19.2M5.0%
Gilead Sciences, Inc.111KUS$14M3.7%
Amgen Inc.35,457US$12.8M3.4%
Thermo Fisher Scientific Inc22,487US$11.3M3.0%
Vertex Pharmaceuticals Incorporated21,484US$10.7M2.8%
Edwards Lifesciences Corporation102KUS$9.26M2.4%
Abbott Laboratories81,496US$7.39M1.9%
Danaher Corporation38,556US$7.34M1.9%
Elevance Health, Inc.18,292US$7.07M1.9%
Pfizer, Inc.237KUS$5.7M1.5%
Argenx Se5,371US$4.98M1.3%
Boston Scientific Corporation116KUS$4.96M1.3%
Biogen Inc.21,727US$4.69M1.2%
Teva Pharmaceutical Industries Limited131KUS$4.43M1.2%
Intuitive Surgical, Inc.11,013US$4.38M1.1%
Stryker Corporation13,291US$4.18M1.1%
Revolution Medicines, Inc.21,425US$4.01M1.1%
Moderna, Inc.54,421US$3.81M1.00%
Waters Corporation10,088US$3.78M0.99%
Cytokinetics, Incorporated39,481US$3.36M0.88%
Regeneron Pharmaceuticals, Inc.5,239US$3.27M0.86%
Bristol-myers Squibb Company54,342US$3.13M0.82%
Humana Inc.7,237US$2.87M0.75%
Cvs Health Corporation27,762US$2.87M0.75%
Astrazeneca Plc15,175US$2.83M0.74%
Incyte Corporation23,632US$2.68M0.70%
Dexcom, Inc.39,665US$2.67M0.70%
Cogent Biosciences, Inc.68,826US$2.66M0.70%
Hca Healthcare, Inc.6,751US$2.63M0.69%
Galderma Group Ag11,157US$2.54M0.67%
Penumbra, Inc.7,995US$2.52M0.66%
Protagonist Therapeutics, Inc.19,754US$2.42M0.63%
Nuvalent, Inc.19,497US$2.41M0.63%
Novartis Ag14,889US$2.33M0.61%
Insmed Incorporated20,560US$2.19M0.57%
Agilent Technologies, Inc.16,087US$2.14M0.56%
Apogee Therapeutics, Inc.15,718US$2.09M0.55%
Idexx Laboratories, Inc.3,919US$2.06M0.54%
Rhythm Pharmaceuticals, Inc.18,084US$2.01M0.53%
United Therapeutics Corporation3,301US$1.79M0.47%
Illumina, Inc.9,950US$1.75M0.46%
Alnylam Pharmaceuticals, Inc.5,633US$1.7M0.44%
Iqvia Holdings, Inc.8,371US$1.62M0.42%
Oruka Therapeutics, Inc.15,857US$1.51M0.40%
Bruker Corporation23,980US$1.44M0.38%
Axsome Therapeutics, Inc.5,320US$1.3M0.34%
Roivant Sciences Ltd.36,604US$1.3M0.34%
Medline Inc.31,350US$1.24M0.32%
Mckesson Corporation1,635US$1.24M0.32%
Kailera Therapeutics, Inc.55,117US$1.21M0.32%
Neurocrine Biosciences, Inc.6,821US$1.15M0.30%
Biomarin Pharmaceutical Inc.19,970US$1.14M0.30%
Mbx Biosciences, Inc.19,741US$1.09M0.29%
Lb Pharmaceuticals Inc33,445US$1.09M0.28%
Quest Diagnostics Incorporated5,093US$1.08M0.28%
Dianthus Therapeutics, Inc.11,071US$1.08M0.28%
Arcus Biosciences, Inc.34,390US$1.06M0.28%
Ucb S.a.3,202US$959K0.25%
Stoke Therapeutics, Inc.28,316US$926K0.24%
Madrigal Pharmaceuticals, Inc.1,659US$891K0.23%
Bio-techne Corp11,772US$832K0.22%
Ionis Pharmaceuticals, Inc.10,319US$818K0.21%
Erasca, Inc.42,899US$786K0.21%
Cencora, Inc.2,761US$781K0.20%
Charles River Laboratories International, Inc.3,410US$773K0.20%
Exelixis, Inc.13,864US$754K0.20%
Scholar Rock Holding Corporation13,630US$750K0.20%
Natera, Inc.2,738US$743K0.19%
Glaukos Corporation5,290US$739K0.19%
Elanco Animal Health Incorporated28,619US$704K0.18%
West Pharmaceutical Services, Inc.1,944US$698K0.18%
Daiichi Sankyo Company, Limited41,900US$674K0.18%
Intellia Therapeutics, Inc.39,811US$674K0.18%
Agios Pharmaceuticals, Inc.16,266US$604K0.16%
Viridian Therapeutics, Inc.31,305US$575K0.15%
Eikon Therapeutics, Inc.43,100US$562K0.15%
Novocure Limited34,399US$521K0.14%
Aktis Oncology, Inc.16,038US$517K0.14%
Vaxcyte, Inc.8,729US$507K0.13%
Alumis Inc.17,411US$490K0.13%
Mettler-toledo International, Inc.365US$466K0.12%
Palvella Therapeutics, Inc.3,008US$460K0.12%
Monte Rosa Therapeutics, Inc.18,858US$456K0.12%
Enanta Pharmaceuticals, Inc.29,263US$427K0.11%
Tango Therapeutics, Inc.12,904US$403K0.11%
Bright Minds Biosciences Inc.5,663US$398K0.10%
Radnet, Inc.6,429US$396K0.10%
Bridgebio Pharma, Inc.5,247US$391K0.10%
Denali Therapeutics Inc.14,927US$384K0.10%
Relay Therapeutics, Inc.20,317US$380K0.10%
Kymera Therapeutics, Inc.3,245US$372K0.10%
Dyne Therapeutics, Inc.16,708US$371K0.10%
Immunome, Inc.17,186US$364K0.10%
Beam Therapeutics Inc.10,063US$345K0.09%
Avalo Therapeutics, Inc.17,980US$332K0.09%
Maze Therapeutics, Inc.10,886US$325K0.09%

Every holding of Health Sciences Portfolio

Source

View original at SEC

Related